Guillaume Daniellot

Guillaume Daniellot serves as CEO of Straumann Holding, the world's largest dental implant company and a growing force in clear aligner orthodontics. Straumann's multi-brand strategy covers the full dental implant market: Straumann (premium segment — the gold standard in dental implantology), Neodent (value segment — particularly strong in Brazil and emerging markets), and Anthogyr (mid-range). In orthodontics, ClearCorrect provides clear aligner therapy competing with Align Technology's Invisalign. The dental implant market is structurally attractive: aging populations lose teeth (tooth loss increases with age), dental awareness and affordability are improving globally, and implants are the best clinical solution for missing teeth (superior to dentures and bridges). However, implant penetration remains low — only a small fraction of missing teeth worldwide are replaced with implants, providing enormous room for growth especially in emerging markets. Straumann has invested heavily in digital dentistry — 3D intraoral scanners, CAD/CAM design software, guided surgery planning, and digital workflows that improve implant placement accuracy and reduce procedure time. The company also manufactures biomaterials (bone graft substitutes) and prosthetic components. Key stock drivers include global dental implant volumes, premium vs. value segment mix, clear aligner market share, digital dentistry adoption, China and emerging market growth, and the competitive dynamics with Nobel Biocare (Envista), Dentsply Sirona, and Align Technology.